Use to detect HIV-1 RNA qualitatively. For quantitative detection, refer to Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT, Plasma (3000867).
Qualitative Transcription-Mediated Amplification
New York DOH Approval Status
Lavender (EDTA), Pink (K2EDTA), Yellow (ACD), or Plasma Preparation Tube (PPT).
Separate from cells within 24 hours of collection. Transfer 2 mL plasma to an ARUP Standard Transport Tube and freeze. (Min: 0.8 mL)
After separation from cells: Ambient: Unacceptable; Refrigerated: 72 hours; Frozen: 90 days
This test detects human immunodeficiency virus type 1 (HIV-1) RNA from Group M, N and O subtypes; it does not detect HIV-1 proviral DNA. A result of "Not Detected" does not rule out HIV-1 RNA concentrations below the limit of detection of the assay or the presence of inhibitors in the patient specimen. The diagnosis of HIV-1 infection should not be made based solely on a single HIV-1 test result. Diagnosis requires repeat and confirmatory testing as recommended by U.S. Health and Human Services Guidelines. Improper specimen handling can cause false negatives or contamination.
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular Tissue-Based Products (HCT/P).
Assay detects HIV-1 virus RNA. Proviral DNA will not be detected.
|Component Test Code*||Component Chart Name||LOINC|
|3003761||HIV-1 Qualitative by NAAT||5017-9|
- HIV 1 RNA
- HIV Qualitative
- HIV1 detection
- Nucleic Acid Amplification Test (NAAT)